Polyomavirus JC urinary shedding in kidney and liver transplant recipients associated with reduced creatinine clearance

Journal of Infectious Diseases

Volumn 206, Issue 6, 2012, Pages 875-880

  Kusne, Shimon ^a   Vilchez, Regis A ^b,d   Zanwar, Preeti ^b   Quiroz, Jorge ^c   Mazur, Marek J ^a   Heilman, Raymond L ^a   Mulligan, David ^a   Butel, Janet S ^b  

^a MAYO CLINIC   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d ROCHE MOLECULAR SYSTEMS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BK VIRUS; CHRONIC GRAFT REJECTION; CREATININE CLEARANCE; DISEASE ASSOCIATION; FEMALE; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; JC VIRUS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIRUS EXCRETION; VIRUS LOAD; VIRUS REACTIVATION; VIRUS SHEDDING;

BK VIRUS; CREATININE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; JC VIRUS; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYOMAVIRUS INFECTIONS; RISK FACTORS; TUMOR VIRUS INFECTIONS; VIRAL LOAD; VIRUS SHEDDING;

EID: 84865754811     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis469     Document Type: Article

References (46)

1. Kean JM, Rao S, Wang M, Garcea RL. Seroepidemiology of human polyomaviruses. PLoS Pathog 2009; 5:e1000363.
2. Egli A, Infanti L, Dumoulin A, et al. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis 2009; 199:837-46.
3. Knowles WA. Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus ( JCV). In: Ahsan N, ed. Polyomaviruses and human disease. Vol 577. Georgetown, TX: Landes Bioscience, 2006:19-45.
4. Doerries K. Human polyomavirus JC and BK persistent infection. In: Ahsan N, ed. Polyomaviruses and human diseases. Georgetown, TX: Landes Bioscience, 2006:102-16.
5. Tan CS, Ellis LC, Wüthrich C, et al. JC virus latency in the brain and extraneural organs of patients with and without progressive multifocal leukoencephalopathy. J Virol 2010; 84:9200-9.
6. Vilchez RA, Kusne S. Molecular and clinical perspectives of polyomaviruses: emerging evidence of importance in non-kidney transplant populations. Liver Transpl 2006; 12:1457-63.
7. White MK, Khalili K. Pathogenesis of progressive multifocal leukoencephalopathy-revisited. J Infect Dis 2011; 203:578-86.
8. Ramos E, Drachenberg CB, Wali R, Hirsch HH. The decade of polyomavirus BK-associated nephropathy: state of affairs. Transplantation 2009; 87:621-30.
9. Boothpur R, Brennan DC. Human polyoma viruses and disease with emphasis on clinical BK and JC. J Clin Virol 2010; 47:306-12.
10. Brew BJ, Davies NWS, Cinque P, Clifford DB, Nath A. Progressive multifocal leukoencephalopathy and other forms of JC virus disease. Nat Rev Neurol 2010; 6:667-79.
11. Tevethia SS, Schell TD. The immune response to SV40, JCV, and BKV. In: Khalili K, Stoner GL, eds. Human polyomaviruses: molecular and clinical perspectives. New York: Wiley-Liss, 2001:585-610.
12. Chen YP, Trofe J, Gordon J, et al. Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy. J Virol 2006; 80:3495-505.
13. Ramaswami B, Popescu I, Macedo C, et al. HLA-A01-,-A03-, and-A024-binding nanomeric epitopes in polyomavirus BK large T antigen. Human Immunol 2009; 70:722-8.
14. Marzocchetti A, Lima M, Tompkins T, et al. Efficient in vitro expansion of JC virus-specific CD8+ T-cell responses by JCV peptide-stimulated dendritic cells from patients with progressive multifocal leukoencephalopathy. Virology 2009; 383:173-7.
15. Hirsch HH, Randhawa P, the AST Infectious Diseases Community of Practice. BK virus in solid organ transplant recipients. Am J Transplant 2009; 9:S136-46.
16. Vats A, Randhawa PS, Shapiro R. Diagnosis and treatment of BK virus-associated transplant nephropathy. In: Ahsan N, ed. Polyomaviruses and human diseases. Georgetown, TX: Landes Bioscience, 2006:213-27.
17. Berger JR, Nath A. Clinical progressive multifocal leukoencephalopathy: diagnosis and treatment. In: Khalili K, Stoner GL, eds. Human polyomaviruses: molecular and clinical perspectives. New York: Wiley-Liss, 2001:237-56.
18. Tan CS, Koralnik IJ. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol 2010; 9:425-37.
19. Shitrit D, Lev N, Bar-Gil-Shitrit A, Kramer MR. Progressive multifocal leukoencephalopathy in transplant recipients. Transpl Int 2005; 17:658-65.
20. Mateen FJ, Muralidharan R, Carone M, et al. Progressive multifocal leukoencephalopathy in transplant recipients. Ann Neurol 2011; 70:305-22.
21. Verhelst X, Vanhooren G, Vanopdenbosch L, et al. Progressive multifocal leukoencephalopathy in liver transplant recipients: a case report and review of the literature. Transplant Int 2011; 24:e30-4.
22. Kazory A, Ducloux D, Chalopin JM, Angonin R, Fontanière B, Moret H. The first case of JC virus allograft nephropathy. Transplantation 2003; 76:1653-5.
23. Kantarci G, Eren Z, Demirag A, Dogan I, Çakalagaoglu F, Yilmaz G. JC virus-associated nephropathy in a renal transplant recipient and comparative analysis of previous cases. Transpl Infect Dis 2011; 13:89-92.
24. Drachenberg CB, Hirsch HH, Papadimitriou JC, et al. Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation. Transplantation 2007; 84:323-30.
25. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349:931-40.
26. Wilkinson AH, Cohen DJ. Renal failure in the recipients of nonrenal solid organ transplants. J Am Soc Nephrol 1999; 10:1136-44.
27. Halloran PF. Immunosuppressive drugs for kidney transplantation. N Engl J Med 2004; 351:2715-29.
28. Rhee J, Al-Mana N, Cooper J, Freeman R. Immunosuppressive agents. In: Bowden RA, Ljungman P, Snydman DR, eds. Transplant infections. 3rd ed. New York: Lippincott Williams & Wilkins, 2010:26-40.
29. Robinson JD, Lupkiewicz SM, Palenik L, Lopez LM, Ariet M. Determination of ideal body weight for drug dosage calculations. Am J Hosp Pharm 1983; 40:1016-9.
30. Thomas LD, Vilchez RA, White ZS, et al. A prospective longitudinal study of polyomavirus shedding in lung-transplant recipients. J Infect Dis 2007; 195:442-9.
31. Thomas LD, Milstone AP, Vilchez RA, Zanwar P, Butel JS, Dummer JS. Polyomavirus infection and its impact on renal function and longterm outcomes after lung transplantation. Transplantation 2009; 88:360-6.
32. McNees AL, White ZS, Zanwar P, Vilchez RA, Butel JS. Specific and quantitative detection of human polyomaviruses BKV, JCV, and SV40 by real time PCR. J Clin Virol 2005; 34:52-62.
33. Randhawa P, Uhrmacher J, Pasculle W, et al. A comparative study of BK and JC virus infections in organ transplant recipients. J Med Virol 2005; 77:238-43.
34. Pires EP, Bernardino-Vallinoto CV, Alves DM, et al. Prevalence of infection by JC and BK polyomaviruses in kidney transplant recipients and patients with chronic renal disease. Transpl Infect Dis 2011; 13:633-7.
35. Cheng XS, Bohl DL, Storch GA, et al. Inhibitory interactions between BK and JC virus among kidney transplant recipients. J Am Soc Nephrol 2011; 22:825-31.
36. Limaye AP, Smith KD, Cook L, et al. Polyomavirus nephropathy in native kidneys of non-renal transplant recipients. Am J Transpl 2005; 5:614-20.
37. Muñoz P, Fogeda M, Bouza E, et al. Prevalence of BK virus replication among recipients of solid organ transplants. Clin Infect Dis 2005; 41:1720-5.
38. Loeches B, Valerio M, Palomo J, Bouza E, Muñoz P. BK virus in heart transplant recipients: a prospective study. J Heart Lung Transplant 2011; 30:109-11.
39. Brinkert F, Briem-Richter A, Ilchmann C, Kemper MJ, Ganschow R. Prevalence of polyomavirus viruria ( JC virus/BK virus) in children following liver transplantation. Pediatr Transplant 2010; 14:105-8.
40. Barton TD, Blumberg EA, Doyle A, et al. A prospective cross-sectional study of BK virus infection in non-renal solid organ transplant recipients with chronic renal dysfunction. Transpl Infect Dis 2006; 8:102-7.
41. Doucette KE, Pang XL, Jackson K, et al. Prospective monitoring of BK polyomavirus infection early posttransplantation in nonrenal solid organ transplant recipients. Transplantation 2008; 85:1733-6.
42. Schwarz A, Mengel M, Haller H, Niedermeyer J. Polyoma virus nephropathy in native kidneys after lung transplantation. Am J Transplant 2005; 5:2582-5.
43. Salama M, Boudville N, Speers D, Jeffrey GP, Ferrari P. Decline in native kidney function in liver transplant recipients is not associated with BK virus infection. Liver Transpl 2008; 14:1787-92.
44. Loeches B, Valerio M, Pérez M, et al. BK virus in liver transplant recipients: a prospective study. Transplant Proc 2009; 41:1033-7.
45. Barraclough KA, Isbel NM, Staatz CE, Johnson DW. BK virus in kidney transplant recipients: the influence of immunosuppression. J Transplant 2011; 2011:e750836.
46. Brennan DC, Agha I, Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005; 5:582-94.